Pokerchips5 May 2023 14:04
Well said-Poker chips.
This is what Avion said about their submission to the FDA. There seems to be some degree of confidence that they have taken on board the guidance from the FDA in framing this latest submission and that they will get the go ahead. Of course there will be potholes in the road (Nolupus) but at least the journey will probably re-commence.
Commenting further, Art Deas, CEO of Avion said:
“We remain committed to our full support of ImmuPharma, and with insights gained from last year’s PK study and invaluable guidance from the FDA, we believe we have submitted the most robust clinical protocol for Lupuzor™.”